Considering the biological role of targeted microRNAs that block transcription and delay translation, we sought to describe its powerful inhibitory effect on cell proliferation, and FOXO3a, as a focus of tumour research, clearly interacts with microRNAs, making it another key therapeutic candidate to review. The gene discussed is FOXO3; the disease is neoplasm.